4-25159110-TAAAAA-TAAAA
Variant names:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_016955.4(SEPSECS):c.115-4delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0463 in 1,435,624 control chromosomes in the GnomAD database, including 188 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.040 ( 181 hom., cov: 26)
Exomes 𝑓: 0.047 ( 7 hom. )
Consequence
SEPSECS
NM_016955.4 splice_region, intron
NM_016955.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -2.42
Genes affected
SEPSECS (HGNC:30605): (Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase) The amino acid selenocysteine is the only amino acid that does not have its own tRNA synthetase. Instead, this amino acid is synthesized on its cognate tRNA in a three step process. The protein encoded by this gene catalyzes the third step in the process, the conversion of O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec).[provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 4-25159110-TA-T is Benign according to our data. Variant chr4-25159110-TA-T is described in ClinVar as [Benign]. Clinvar id is 1296157.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr4-25159110-TA-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0943 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0403 AC: 5680AN: 141002Hom.: 181 Cov.: 26
GnomAD3 genomes
AF:
AC:
5680
AN:
141002
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0469 AC: 60715AN: 1294540Hom.: 7 Cov.: 22 AF XY: 0.0466 AC XY: 30012AN XY: 643802
GnomAD4 exome
AF:
AC:
60715
AN:
1294540
Hom.:
Cov.:
22
AF XY:
AC XY:
30012
AN XY:
643802
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0404 AC: 5694AN: 141084Hom.: 181 Cov.: 26 AF XY: 0.0402 AC XY: 2749AN XY: 68346
GnomAD4 genome
AF:
AC:
5694
AN:
141084
Hom.:
Cov.:
26
AF XY:
AC XY:
2749
AN XY:
68346
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Aug 10, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Pontocerebellar hypoplasia type 2D Benign:1
Sep 27, 2019
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at